Listing & Compliance Notices

Kiromic Biopharma, Inc. received a nasdaq delisting notice notice regarding other.

“September 12, 2023, Kiromic Biopharma, Inc. (the “Company”) received written notice (the “Notice”) from the Nasdaq Stock Market, LLC (“Nasdaq”) that it would delist the Company’s shares of common stock from the Nasdaq Capital Market upon the opening of trading on September 14, 2023. The Company’s common stock will be traded on the OTC Pink Sheets while it pursues an uplisting to the OTCQB exchange and seeks to establish relationships with market makers to provide additional trading opportunities in the Company’s stock. However, there can be no assurance that a market for the Company’s shares w”

EXICURE, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“September 13, 2023, Exicure, Inc. (the “Company”) received a letter (the “Notice”) from the staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the previous 30 consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Requirement”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A) (the “Compliance Period Rule”), the Company has been provided an initial period of 180 calendar d”

Avalo Therapeutics, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5550(b)(2), 5810(c)(3)(A), 5810(c)(3)(C), 5810(c)(3)(A)(iii)).

“September 12, 2023, the Company received notice (the “September 12 Letter”) from Nasdaq that Nasdaq had determined that as of September 11, 2023, the Company’s securities had a closing bid price of $0.10 or less for ten consecutive trading days triggering application of Listing Rule 5810(c)(3)(A)(iii) which states in part: if during any compliance period specified in Rule 5810(c)(3)(A), a company’s security has a closing bid price of $0.10 or less for ten consecutive trading days, the Listing Qualifications Department shall issue a Staff Delisting Determination under Rule 5810 with respect to”

CorEnergy Infrastructure Trust, Inc. received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).

“September 12, 2023, CorEnergy Infrastructure Trust, Inc. (the “Company”) received a notice (the “Notice”) from the New York Stock Exchange (“NYSE”) that it is not in compliance with the continued listing standard set forth in Section 802.01C of the NYSE's Listed Company Manual (“Section 802.01C”) because the average closing price of the Company's common stock was less than $1.00 per share over a consecutive 30 trading-day period. The Notice has no immediate effect on the listing of the Company's common stock on the NYSE, subject to the Company's compliance with the NYSE's other continued listi”

Piermont Valley Acquisition Corp received a nasdaq deficiency notice notice regarding other (rules 5450(a)(2)).

“September 7, 2023, Capitalworks Emerging Markets Acquisition Corp (the “ Company ”) received a written notice (the “ Notice ”) from the Listing Qualifications Department (the “ Staff ”) of The Nasdaq Stock Market (“ Nasdaq ”) notifying the Company that the Company was not in compliance with Listing Rule 5450(a)(2), which requires the Company to have at least 400 shareholders for continued listing on the Nasdaq Global Market (the “ Minimum Total Holders Rule ”). The Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the”

Streamex Corp. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“September 6, 2023, BioSig Technologies, Inc. (the “Company”) received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock for the 30 consecutive business days between July 25, 2023, to September 5, 2023, the Company did not meet the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2). The letter also indicated that the Company will be provided with a compliance period of 180 calendar days, o”

CEMTREX INC received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5555(a)(1)).

“January 5, 2024, and described the actions it intends to take to be able to meet that timeline. Accordingly, the Company has been granted an exception until January 19, 2024, to effect the reverse stock split and thereafter regain compliance with the Bid Price Rule.”

DIRTT ENVIRONMENTAL SOLUTIONS LTD received a nasdaq compliance regained notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

“March 7, 2023, Nasdaq notified the Company in writing that while the Company had not regained compliance with the Bid Price Rule, it was eligible for an additional 180 calendar day period, or until September 5, 2023, to regain compliance with the Bid Price Rule. The Company’s securities were transferred to The Nasdaq Capital Market at the opening of business on March 9, 2023. The Company did not regain compliance before the additional 180-day period expired on September 5, 2023. On September 6, 2023, the Company received notice from the Nasdaq that the Company's shares would be delisted. The C”

Cactus Acquisition Corp. 1 Ltd received a nasdaq deficiency notice notice regarding shareholders (rules 5450(a)(2)).

“September 8, 2023, Cactus Acquisition Corp. 1 Ltd., a Cayman Islands exempted company (the “ Company ”), received a written notice (the “ Notice ”) from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market (“ Nasdaq ”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5450(a)(2), which requires the Company to maintain at least 400 total holders for continued listing on the Nasdaq Global Market (the “ Minimum Total Holders Rule ”). The Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or t”

Cano Health, Inc. received a nyse noncompliance notice notice regarding minimum bid price (rules 802.01C).

“September 5, 2023, Cano Health, Inc. (“ Cano Health ” or the “ Company ”) was notified by NYSE Regulation Inc. (the “ NYSE ”) that it is not in compliance with Section 802.01C of the NYSE Listed Company Manual (the “ Listing Rule ”) because the average closing stock price of a share of the Company’s Class A common stock was less than $1.00 per share over a consecutive 30 trading-day period. Pursuant to the Listing Rule, the Company has 6 months following the NYSE notification to regain compliance with the Listing Rule, during which time the Company’s Class A common stock will continue to be li”

Reborn Coffee, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1), 5810(c)(2)(A)(i)).

“received a notification letter (the “Letter”) from the Nasdaq Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that its amount of stockholders’ equity has fallen below the $2,500,000 required minimum for continued listing set forth in Nasdaq Listing Rule 5550(b)(1). The Company’s stockholders’ equity currently sits at $2,278,723 as reported by our Quarterly Report on Form 10-Q for the period ended June 30, 2023. The Letter also noted that as of June 30, 2023, the Company does not meet the alternatives of market value listed securities or net income”

INFINITY PHARMACEUTICALS, INC. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(C), 5810(c)(3)(D)).

“September 5, 2023, Infinity Pharmaceuticals, Inc. (the “Company”) received a letter (the “Letter”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the listing of its common stock was not in compliance with Nasdaq Listing Rule 5450(b)(2)(C) (the “Minimum MVPHS Requirement”) for continued listing on The Nasdaq Global Select Market, as the market value of the Company’s publicly held shares was less than $15,000,000 for each of the previous 30 consecutive business days. In accordance with Nasdaq Listing Rule 5810(c)(3)(D”

Cadrenal Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“September 6, 2023, Cadrenal Therapeutics, Inc. (the “Company”) received a letter from The Nasdaq Stock Market (“Nasdaq”) stating that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2) (the “Rule”), requiring listed securities to maintain a minimum bid price of $1.00 per share because the Company’s closing bid price for the last 30 consecutive business days was below $1.00 per share. The notification received has no immediate effect on the Company’s continued listing on the Nasdaq Capital Market, subject to the Company’s compliance with the other continued listing requiremen”

CERO THERAPEUTICS HOLDINGS, INC. received a nasdaq deficiency notice notice regarding other (rules 5450(a)(2)).

“September 7, 2023, Phoenix Biotech Acquisition Corp., a Delaware corporation (the “Company”), received a written notice (the “Notice”) from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company was not in compliance with Listing Rule 5450(a)(2), which requires the Company to have at least 400 public holders for continued listing on the Nasdaq Global Market (the “Minimum Public Holders Rule”). The Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Company’s se”

ZyVersa Therapeutics, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(1)(C), 5810(c)(3)(D)).

“September 1, 2023, ZyVersa Therapeutics, Inc. (the “Company”) received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market, LLC (“Nasdaq”) stating that for the last 30 consecutive business days, the Company is not in compliance with the requirement of a minimum Market Value of Publicly Held Shares (“MVPHS”) of $5,000,000 for continued listing on the Nasdaq Global Market, as set forth in Nasdaq Listing Rule 5450(b)(1)(C). Nasdaq calculates MVPHS by subtracting from the total shares of common stock outstanding any shares held by officers, directors or any person who benefic”

Nogin, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

“September 5, 2023, Nogin, Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, based on the closing bid price of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), for the last 30 consecutive trading days, the Company no longer complies with the minimum bid price requirement for continued listing on The Nasdaq Global Market. Nasdaq Listing Rule 5450(a)(1) requires listed securities to maintain a minimum bid price of $1.00 per share (the “Minimum B”

MSP Recovery, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5810(3)(A)(iii), 5450(a)(1)).

“September 5, 2023, the Company received a determination from the Staff that the Company’s Class A common stock, par value $0.0001 (“ Class A Common Stock ”), had a closing bid price of $0.10 for 10 consecutive trading days during a compliance period and so, pursuant to Listing Rule 5810(3)(A)(iii), the staff determined to delist the Company’s securities from The Nasdaq Capital Market (the “ Delisting Determination ”). Pursuant to the procedures set out in the Nasdaq Listing Rules, the Company will appeal the Delisting Determination to a hearing panel (the “ Hearing ”), which will suspend the D”

IMAC Holdings, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A), 5810(c)(3)(A)(iii)).

“September 6, 2023, the Company received a written notice from Nasdaq’s Listing Qualifications Department (the “ September 2023 Notice ”) notifying that, because the bid price for the Company’s voting common stock, par value $0.001 per share (the “ Common Stock ”) and warrants (the “ Warrants ”), had closed at $0.10 or less for the preceding ten consecutive trading days, in contravention of Nasdaq Listing Rule 5810(c)(3)(A)(iii), the Company’s securities were subject to delisting unless the Company requested a hearing before the Nasdaq Hearings Panel (the “ Panel ”) no later than September 13”

FORUM MARKETS Inc received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“September 7, 2023, 180 Life Sciences Corp. (the “ Company ”, “ we ” or “ us ”) received written notice (the “ Notification Letter ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that it is not in compliance with the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share, and Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid pric”

Tempest Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“September 6, 2023, Tempest Therapeutics, Inc., a Delaware corporation (the “Company”), received a letter from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that for the last 30 consecutive business days, the bid price of the Company’s common stock had closed below $1.00 per share, the minimum closing bid price required by the continued listing requirements of Nasdaq Listing Rule 5550(a)(2). The notification received has no immediate effect on the listing of the Company’s common stock on the Nasdaq Stock Market. In accordance with”

ESPORTS ENTERTAINMENT GROUP, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A), 5810(b)).

“September 6, 2023, Esports Entertainment Group, Inc. (the “Company”) received a deficiency notification letter from the Listing Qualifications Staff of the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2) because the bid price for the Company’s common stock had closed below $1.00 per share for longer than the previous 30 consecutive business days. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has 180 calendar days from the date of such notice, or until March 4, 2024, to regain compliance with the minimu”

REMARK HOLDINGS, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“September 6, 2023, Remark Holdings, Inc. (“we” or “our”) received a letter from The Nasdaq Stock Market (“Nasdaq”) stating that we were not in compliance with Nasdaq Listing Rule 5550(a)(2) (the “Rule”), requiring listed securities to maintain a minimum bid price of $1.00 per share because our closing bid price for the last 31 consecutive business days was below $1.00 per share. The notification received has no immediate effect on our continued listing on the Nasdaq Capital Market, subject to our compliance with the other continued listing requirements. Pursuant to the Rule, we have 180 calend”

Clover Leaf Capital Corp. received a nasdaq deficiency notice notice regarding other (rules 5550(a)(3)).

“August 31, 2023, Clover Leaf Capital Corp. (the “Company”) received a deficiency letter from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that the Company no longer meets the minimum 300 public holders requirement for The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(3) (the “Minimum Public Holders Requirement”). The notification received has no immediate effect on the Company’s Nasdaq listing. In accordance with Nasdaq rules, the Company has 45 calendar days, or until October 16, 2023 to submit a plan to regain”

Aligos Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

“rough September 1, 2023, the Company’s common stock, $0.0001 par value per share (the “Common Stock”), had not maintained a minimum bid price of $1.00 per share, required for continued listing on the Nasdaq Global Select Market pursuant to Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”). Nasdaq’s written notice does not result in the immediate delisting of the Common Stock from the Nasdaq Global Market In accordance with Nasdaq Listing Rule 5810(c)(3)(A) (the “Compliance Period Rule”), the Company has 180 calendar days, or until March 4, 2024 (the “Compliance Date”), to regain compliance with the Minimum Bid Price Requirement.”

Shuttle Pharmaceuticals Holdings, Inc. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“f $1.00 per share, as required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has an initial period of 180 calendar days,”

Spark Networks SE received a nasdaq delisting notice notice regarding other (rules 5550(b)(1)).

“which requires that a listed company’s stockholders’ equity be at least $2.5 million. As reported on its Form 10-K, the Company reported stockholders’ deficit of approximately $(6,786,000). In addition, as of April 18, 2023, the Company did not meet the alternative compliance standards relating to the market value of listed securities or net income from continuing”

Aclarion, Inc. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)(1), 5550(a)(2)).

“August 31, 2023, the Nasdaq staff notified the Company that it had not met the terms of the Extension Notice. Accordingly, the Nasdaq staff had determined to delist the Company’s common stock from Nasdaq, unless the Company timely requests an appeal of the staff’s determination to a hearings panel (the “Panel”), pursuant to the procedures set forth in the Nasdaq Listing Rule 5800 Series. The Company has requested a hearing before the Panel to appeal the delisting notice from the staff. While the appeal process is pending, the suspension of trading of the Company’s common stock will be stayed.”

BOLLINGER INNOVATIONS, INC. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5550(a)(2)).

“Department of The Nasdaq Stock Market (the “Staff”) notified Mullen Automotive Inc. (the “Company”) that the bid price of the Company’s common stock had closed at less than $1.00 per share over the previous 30 consecutive business days, and, as a result, did not comply with Listing Rule 5550(a)(2) (the “Bid Price Rule”). Therefore, in accordance with”

Angel Studios, Inc. received a nyse noncompliance notice notice regarding late filing (rules 802.01E).

“August 22, 2023, Southport Acquisition Corporation (the “ Company ”) received a notice from the New York Stock Exchange (the “ NYSE ”) indicating that the Company is not in compliance with the NYSE’s continued listing requirements under the timely filing criteria set forth in Section 802.01E of the NYSE Listed Company Manual since the Company did not file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2023 (the “ Form 10-Q ”) with the Securities and Exchange Commission (the “ SEC ”) on or before August 21, 2023, the extended period provided for the filing under Rule 12b-25(b)”

KORE Group Holdings, Inc. received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).

“September 5, 2023, KORE Group Holdings, Inc., a Delaware corporation (“ KORE ”), received notice (the “ Notice ”) that as of August 30, 2023, it was not in compliance with the continued listing standard set forth in Section 802.01C of the NYSE’s Listed Company Manual (“ Section 802.01C ”) because the average closing price of KORE’s Common Stock, $0.0001 par value per share (“ Common Stock ”) was less than $1.00 per share over a consecutive 30 trading-day period. The Notice has no immediate impact on the listing of the Common Stock on the NYSE, subject to KORE’s compliance with the NYSE’s other”

Atlantic Coastal Acquisition Corp. received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).

“August 17, 2023, the Company received notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) that the Company was not in compliance with Nasdaq’s continued listing standards (the “Listing Rules”) as set forth in Listing Rule 5250(c)(1) given the Company’s failure to timely file the Report. Consistent with the Listing Rules, the Company has 60 calendar days from the date of the Notice to provide Nasdaq with a specific plan to achieve and sustain compliance with the Listing Rules. The Company expects to file the Report in the coming weeks. On August 25, 2023, the Company issued a pres”

Decoy Therapeutics Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“September 5, 2023, Salarius Pharmaceuticals, Inc. (the “Company”) was notified (the “Notice”) by Nasdaq Stock Market, LLC (“Nasdaq”) that on September 1, 2023, the average closing price of the Company’s common stock (the “Common Stock”) over the prior 30 consecutive trading days had fallen below $1.00 per share, which is the minimum average closing price required to maintain listing on Nasdaq under Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Requirement”). The Notice has no immediate effect on the listing or trading of the Company’s common stock. In accordance with Nasdaq Listing Rule 581”

1847 Holdings LLC received a nyse_american deficiency notice notice regarding minimum bid price (rules 1003(f)(v)).

“August 31, 2023, 1847 Holdings LLC (the “Company”) received written notice (the “Notice”) from the NYSE American LLC (the “NYSE American”) stating that it is not in compliance with the continued listing standard set forth in Section 1003(f)(v) of the NYSE American Company Guide (the “Company Guide”) because the Company’s common shares were selling for a substantial period of time at a low price per share, which NYSE American determined to be a 30-trading day average of less than $0.20 per share. The Notice stated that the Company’s continued listing is predicated on it effecting a reverse spli”

DBX ETF TRUST received a nyse deficiency notice notice regarding other.

“August 15, 2023, the Regulation Staff (the “Staff”) of the NYSE provided written notice to DBX ETF Trust (the “Trust”) that it is not in compliance with the continued listing standard of NYSE Arca, Inc. (the “Exchange”) set forth in NYSE Arca Rule 5.2-E(j)(8)(e)(2)(C) that requires that after the twelve-month anniversary of initial listing on the Exchange, an ETF is required to maintain at least 50 beneficial holders. Xtrackers Net Zero Pathway Paris Aligned US Equity ETF (the “Fund”), a series of the Trust, was reported to have less than 50 beneficial shareholders as of August 3, 2023. In acc”

DIRTT ENVIRONMENTAL SOLUTIONS LTD received a nasdaq compliance regained notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

“March 7, 2023, Nasdaq notified the Company in writing that while the Company had not regained compliance with the Bid Price Rule, it was eligible for an additional 180 calendar day period, or until September 5, 2023, to regain compliance with the Bid Price Rule. The Company’s securities were transferred to The Nasdaq Capital Market at the opening of business on March 9, 2023. The Company did not regain compliance before the additional 180-day period expired on September 5, 2023. On September 6, 2023, the Company received notice from the Nasdaq that the Company's shares would be delisted. The C”

Adamas One Corp. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“” or the “ Registrant ”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) indicating that, since the Company has not yet filed its Quarterly Report on Form 10-Q for the period ended June 30, 2023, it no longer complies with Nasdaq Listing Rule 5250(c)(1) for continued listing. As a result of this delinquency of not timely filing the Form 10-Q , the Company now has 60 calendar days, until October 30, 2023 (the first business day after the 60 th calendar day), to submit a plan to regain compliance and if Nasdaq accepts such plan, Nasdaq may”

SpringBig Holdings, Inc. received a nasdaq delisting notice notice regarding market value (rules 5450(b)(2)(A)).

“September 1, 2023, (i) the Board of Directors of SpringBig Holdings, Inc. (the “Company”) determined that it would not be in the best interest of the Company or its shareholders to meet the continued listing requirements of the Nasdaq Capital Market, (ii) the Company notified the Nasdaq Stock Market LLC (“Nasdaq”) that it was withdrawing its appeal of the Nasdaq Listings Qualification staff’s delist determination dated March 7, 2023, for the Company’s failure to meet the market value of listed securities requirement in Nasdaq Listing Rule 5450(b)(2)(A) and (iii) the Company received a letter f”

1847 Holdings LLC received a nyse_american deficiency notice notice regarding market value (rules 1003(f)(v)).

“August 31, 2023, 1847 Holdings LLC (the “Company”) received written notice (the “Notice”) from the NYSE American LLC (the “NYSE American”) stating that it is not in compliance with the continued listing standard set forth in Section 1003(f)(v) of the NYSE American Company Guide (the “Company Guide”) because the Company’s common shares were selling for a substantial period of time at a low price per share, which NYSE American determined to be a 30-trading day average of less than $0.20 per share. The Notice stated that the Company’s continued listing is predicated on it effecting a reverse spli”

VISION SENSING ACQUISITION CORP. received a nasdaq deficiency notice notice regarding shareholders (rules 5450(a)(2)).

“August 28, 2023, Vision Sensing Acquisition Corp., a Delaware corporation (the “ Company ”), notified the Listing Qualifications Department of The Nasdaq Stock Market (“ Nasdaq ”) that the number of Total Holders (which includes both beneficial holders and holders of record) of the Company’s common stock was less than 400 based on a shareholder analysis provided by the Company at Nasdaq’s request to Nasdaq on August 28, 3023, and that, therefore, the Company was no longer in compliance with the Nasdaq Global Market continued listing criteria set forth in Listing Rule 5450(a)(2) that requires t”

Lightning eMotors, Inc. received a nyse noncompliance notice notice regarding market value (rules 802.01B).

“August 29, 2023, Lightning eMotors, Inc. (the “Company”) received written notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that the Company was not in compliance with the continued listing standard set forth in Section 802.01B of the NYSE’s Listed Company Manual because the average global market capitalization of the Company over a consecutive 30 trading-day period was less than $50 million and, at the same time, the Company’s last reported stockholders’ equity was less than $50 million. In accordance with applicable NYSE procedures, the Company has 45 days from receipt of t”

Passage BIO, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

“August 31, 2023, Passage Bio, Inc. (the “ Company ”) received notice (the “ Notice ”) from the Listing Qualifications staff of the Nasdaq Stock Market LLC (“ Nasdaq ”) that, because the closing bid price for the Company’s common stock has fallen below $1.00 per share for 30 consecutive business days, the Company no longer complies with the minimum bid price requirement for continued listing on the Nasdaq Global Select Market under Nasdaq Listing Rule 5450(a)(1). The Notice has no immediate effect on the listing of the Company’s common stock on the Nasdaq Global Select Market. Pursuant to Nasda”

Nxu, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“August 29, 2023, Nxu, Inc. (the “Company”) received a notice (“Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) stating that, based on Nasdaq’s review of the Company’s Form 10-Q for the period ended June 30, 2023, the Company’s reported stockholders’ equity no longer meets the minimum stockholders’ equity of $2,500,000 required for continued listing of the Company’s Class A common stock on Nasdaq under Nasdaq Listing Rule 5550(b)(1) (the “Rule”). The Company does not meet any of the alternatives of market value of listed securities or net income from continued operations to otherwise satis”

Genprex, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“August 30, 2023, Genprex, Inc. (the “Company”) received a letter from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that, based upon the closing bid price of the Company’s common stock, par value $0.001 per share (“Common Stock”), for the last 30 consecutive business days, the Company is not currently in compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing on The Nasdaq Capital Market as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). The Nasd”

Notable Labs, Ltd. received a nasdaq delisting notice notice regarding minimum bid price (rules 5450(a)(1), 5550(a)(2), 5810(c)(3)(A)(ii)).

“August 29, 2023, VBL was notified by Nasdaq that it had not regained compliance with the Minimum Bid Price Requirement. VBL intends to timely request a hearing before the Nasdaq Hearings Panel (the “Panel”), which will stay the suspension of VBL’s ordinary shares pending the Panel’s conclusion of the hearing process. VBL intends to request the extension to regain compliance on the basis that completion of the pending merger transaction and reverse stock split, as described in the amended registration statement on Form S-4 filed with the U.S. Securities and Exchange Commission on September 1, 2”

TREVENA INC received a nasdaq extension granted notice regarding minimum bid price (rules 5810(c)(3)(A)).

“September 1, 2023, Trevena, Inc. (the “Company”) received a letter (the “Notice”) from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market indicating that, for the last 30 consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share required for continued inclusion on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Requirement”). The Notice has no effect at this time on the listing of the Company’s common stock, which will continue to trade on The Nasdaq Capital Market under the sy”

TREVENA INC received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“September 1, 2023, Trevena, Inc. (the “Company”) received a letter (the “Notice”) from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market indicating that, for the last 30 consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share required for continued inclusion on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Requirement”). The Notice has no effect at this time on the listing of the Company’s common stock, which will continue to trade on The Nasdaq Capital Market under the sy”

Netcapital Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“LC (“Nasdaq”) that it is not in compliance with the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid”

FOXO TECHNOLOGIES INC. received a nyse_american noncompliance notice notice regarding minimum bid price (rules 1003(f)(v)).

“August 16, 2023, from NYSE American stating that it is not in compliance with the continued listing standard set forth in Section 1003(f)(v) of the Company Guide because the Company’s Class A common stock was selling for a substantial period of time at a low price per share, which NYSE American determined to be a 30-trading day average of less than $0.20 per share. The Second Notice stated that the Company’s continued listing is predicated on it effecting a reverse stock split of its Class A common stock or otherwise demonstrating sustained price improvement within a reasonable period of time”

FOXO TECHNOLOGIES INC. received a nyse_american noncompliance notice notice regarding stockholders equity (rules 1003(a)(i)).

“June 12, 2023, FOXO Technologies Inc. (the “Company”) received a notice (the “Notice”) from NYSE American LLC (“NYSE American”) stating that it is not in compliance with the continued listing standards set forth in Section 1003(a)(i) of the NYSE American Company Guide (the “Company Guide”) and requesting that the Company submit a plan of compliance (the “Plan”) addressing how it intends to regain compliance. In response to the Letter, the Company submitted the Plan to NYSE American on July 12, 2023. On August 29, 2023, the Company received a letter from NYSE American stating that NYSE American”

Adaptimmune Therapeutics PLC received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“August 31, 2023, Adaptimmune Therapeutics plc (the “Company”) received a notice from The Nasdaq Stock Market (“Nasdaq”) that the Company is not in compliance with Nasdaq’s Listing Rule 5450(a)(1), because the minimum bid price of the Company’s American Depositary Shares (“ADSs”) has been below $1.00 per share for 30 consecutive business days (the “Notice”). The Notice has no immediate effect on the listing or trading of the Company’s ADSs on The Nasdaq Global Select Market. ​ In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has 180 calendar days, or until February 27, 2024, to”